Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis
about
Molecular prognostic prediction in liver cirrhosisNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentUnique genomic profile of fibrolamellar hepatocellular carcinoma.Screening and surveillance for hepatocellular carcinoma: perspective of a new era?The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis.Host genetics predict clinical deterioration in HCV-related cirrhosis.Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationPathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Hepatitis C virus-induced hepatocellular carcinomaCancer biomarker discovery and validation.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Liver cancer: Approaching a personalized care.Molecular Determinants of Prognosis in Hepatocellular Carcinoma.In vitro reversion of activated primary human hepatic stellate cellsImpact of hepatitis C virus eradication on hepatocellular carcinogenesis.HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular CarcinomaHepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patientsTranscriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyTranscriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells.Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning.Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.Prognostic factors for hepatocellular carcinoma recurrence.Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.
P2860
Q26784251-665D43FA-AFA2-46B2-AC97-16313CF7FE32Q26851211-95FAEADA-6EDE-4F15-AA6F-B75092EC22A8Q27853116-3CC7F2FC-2565-45CC-8026-3555415F90AEQ30244651-55FE0219-0C3E-4BBF-9FAA-3689BDB895CAQ30370881-769A0A8F-1E71-4F72-9B65-54EE2433CBA6Q31138564-97C18FB0-6E93-470F-B0E6-0A00AD46D47DQ33605760-4BF81145-4769-4332-8D76-58C739C5A7A2Q33638900-CF8BCF2D-82F3-4CC7-ABCA-6F0D4A631423Q33863710-DF952044-8DE5-4B01-98FD-133D2FF3256FQ33919936-25FD9171-94E4-47E5-BEC9-0FA1EFFC07F3Q33920344-E801E262-95FF-4FF7-97C4-1FAFCC103E74Q34660374-F8DF616E-0D06-480C-9D57-B589990B3B31Q34689664-218C8ECD-A66C-44B0-A212-488100AB0B23Q34786437-A5C29E90-1762-45AF-88A1-690D78808946Q34991214-F2292CA7-3A70-4F02-84D6-D3C888487364Q35107005-9ABA9B86-E777-45CB-B434-2757F461326CQ35619104-3B420B89-F4D5-4655-B8C8-82E190423249Q35824057-F69854AF-337A-4976-8B9F-F135C696C806Q35879887-573C5BB6-BC1A-4DAA-B24E-8687CD8299B2Q35881575-6F02779B-5CBA-4FD1-ACDE-788636376775Q35903794-C1D1BB5D-B7D4-4822-9B1F-59A6C918B896Q35905975-DF4A3B17-5167-4769-B7B6-F1370E1E015BQ35923294-5B9D7EC7-D1C3-4236-90B2-6DDD37D5D55CQ35985401-3ADDA665-0763-4017-A942-C7A3380DA3D3Q36364376-4C6CEE68-FDF4-4CCA-B124-9D1D74D36F06Q36804715-176E5864-CF8D-429B-9EB8-7D6A45895E82Q36871021-473E3E60-D564-4385-8CA2-7873D01BC997Q36904033-FD71B582-7383-46D1-9E8B-91B87F00BBD4Q37031827-CAB8E4D7-9D71-40A9-B611-47E1C4C9028BQ37398922-60863500-B7D1-428D-948C-0AA09AF4037AQ37534159-CEAE4EF6-4FA4-4E97-AB1D-C51FD6FB1056Q37606028-D440B7C6-EB49-4551-BB4C-1D77288EE5E6Q37678954-43AF19CF-F7EF-470D-AC75-D4F6080CC2D9Q38176242-919EF80F-EC8C-4A20-BBEF-E48101D9E549Q38176402-8E9FE993-220A-439B-A591-B9B87D8C107FQ38216004-598D2077-8452-4BBE-A02A-1ACED2E0925CQ38589516-0267556F-4194-4C5A-BA9A-F3223245D90CQ38726399-E752CF67-5B74-4288-B11D-CBB4AD3B7AA1Q38758644-29850264-151A-4C07-AA5D-6DBF92D33C4BQ38848401-9C9DC872-728A-4DE0-B36D-21B48DEDF6F2
P2860
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prognostic gene expression sig ...... -related early-stage cirrhosis
@en
type
label
Prognostic gene expression sig ...... -related early-stage cirrhosis
@en
prefLabel
Prognostic gene expression sig ...... -related early-stage cirrhosis
@en
P2093
P2860
P50
P1433
P1476
Prognostic gene expression sig ...... -related early-stage cirrhosis
@en
P2093
Andrew Crenshaw
Bradley Taylor
Joshua Gould
Karin L Andersson
Kensuke Kojima
Manel Sole
Massimo Colombo
Raymond T Chung
Scott L Friedman
Stacey Gabriel
P2860
P304
P356
10.1053/J.GASTRO.2013.01.021
P407
P577
2013-01-17T00:00:00Z